InsiderClue
Insiders · Profile

Wilson Martin

General Counsel at ROCKET PHARMACEUTICALS. Filing since 16 Feb 2024. CIK 0001704342

Company
Date
Role
Action
Shares
Amount
Of holding
RCKT ROCKET PHARMACEUTICALS, INC.
11 Sep 2026
General Counsel
Sold at will
75,364
$256.46K
11.2%
RCKT ROCKET PHARMACEUTICALS, INC.
18 Aug 2026
General Counsel
Sold at will
631
$2.13K
0.1%
RCKT ROCKET PHARMACEUTICALS, INC.
13 Aug 2026
General Counsel
Sold at will
3,493
$11.81K
0.5%
RCKT ROCKET PHARMACEUTICALS, INC.
19 May 2026
General Counsel
Sold at will
662
$2.00K
0.1%
RCKT ROCKET PHARMACEUTICALS, INC.
13 May 2026
General Counsel
Sold at will
3,361
$12.12K
0.5%
RCKT ROCKET PHARMACEUTICALS, INC.
18 Feb 2026
General Counsel
Sold at will
1,376
$4.59K
0.2%
RCKT ROCKET PHARMACEUTICALS, INC.
13 Feb 2026
General Counsel
Sold at will
12,253
$40.58K
1.8%
RCKT ROCKET PHARMACEUTICALS, INC.
18 Nov 2025
General Counsel
Sold at will
1,646
$4.91K
0.4%
RCKT ROCKET PHARMACEUTICALS, INC.
19 Aug 2025
General Counsel
Sold at will
588
$1.76K
0.4%
RCKT ROCKET PHARMACEUTICALS, INC.
18 Aug 2025
General Counsel
Sold at will
1,004
$3.08K
0.7%
RCKT ROCKET PHARMACEUTICALS, INC.
14 Aug 2025
General Counsel
Sold at will
12,109
$36.56K
8.1%
RCKT ROCKET PHARMACEUTICALS, INC.
20 May 2025
General Counsel
Sold at will
587
$3.78K
0.4%
RCKT ROCKET PHARMACEUTICALS, INC.
16 May 2025
General Counsel
Sold at will
946
$6.18K
0.6%
RCKT ROCKET PHARMACEUTICALS, INC.
21 Feb 2025
General Counsel
Sold at will
3,222
$34.09K
2.1%
RCKT ROCKET PHARMACEUTICALS, INC.
21 Nov 2024
General Counsel
Sold at will
1,175
$15.34K
1.8%
RCKT ROCKET PHARMACEUTICALS, INC.
16 Aug 2024
General Counsel
Sold at will
1,027
$19.00K
1.6%
RCKT ROCKET PHARMACEUTICALS, INC.
16 May 2024
General Counsel
Sold at will
1,048
$24.47K
1.6%
RCKT ROCKET PHARMACEUTICALS, INC.
29 Feb 2024
General Counsel
Sold at will
4,100
$120.26K
18.0%
RCKT ROCKET PHARMACEUTICALS, INC.
16 Feb 2024
General Counsel
Sold at will
3,576
$106.70K
36.8%
19 decisions on file.